Psoriasis is a common and chronic inflammatory disease of the skin. It may impair the
physical and psychosocial function of patients and lead to decreased quality of life …

Psoriatic arthritis is an inflammatory arthropathy frequently associated with psoriasis and
several other comorbidities. The goal of this review is to summarize the available evidence …

Objective To assess the magnitude of risk of cardiovascular and cerebrovascular morbidity
in patients with psoriatic arthritis (PsA) compared with the general population through a …

Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease with a chronic,
progressive course. Various aspects of PsA, including its clinical features, disease course …

Cardiometabolic comorbidities present a considerable burden for patients with rheumatoid
arthritis (RA) or psoriatic arthritis (PsA). Both RA and PsA are associated with an increased …

There is solid epidemiologic evidence linking psoriasis and psoriatic arthritis (PsA) to
cardiovascular risk factors and an increased risk of develo** cardiovascular disease …

Objective Dactylitis—long considered a hallmark clinical feature of psoriatic arthritis (PsA)—
occurs in 16–49% of patients with PsA. In this review, we discuss the pathology of dactylitis …

Objective To perform an update of a review of the efficacy and safety of disease-modifying
antirheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Methods This is a systematic …

Psoriatic arthritis (PsA) is associated with a higher burden of cardiometabolic disorders,
such as hypertension, dyslipidemia, diabetes, obesity, and cardiovascular disease (CVD) …

Psoriasis (PsO) and psoriatic arthritis (PsA), together known as psoriatic disease (PsD), are
immune-mediated diseases with a chronic and relapsing course that affect the skin, the …